US Patent Issued to Cedars-Sinai Medical Center on July 22 for "Diagnostic testing using microbial biomarkers to classify pelvic and bladder pain" (California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,951, issued on July 22, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Diagnostic testing using microbial biomarkers to classify pelvic and bladder pain" was invented by Anne Lenore Ackerman (Los Angeles) and David M. Underhill (Tarzana, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention describes methods for a method of detecting levels of one or more microorganisms, selecting treatment for interstitial cystitis, pelvic pain, bladder pain and myofascial pain and treating interstitial cystitis, pelvic pain, bladder pain and myofascial pain. The invention also describes detecting bacterial phenotype and kits."

The paten...